Versant Capital Management, Inc: CDNA position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Versant Capital Management, Inc on CDNA, newest first. How the timeline and the estimate are built.
Versant Capital Management, Inc held 689 CDNA shares at 2026-09-30 per its 13F-HR filed 2026-10-02.
the latest 13F is the newest step
- period ended2026-09-3013F 689 sharesChange vs previous 13F -269 shares
<0.01% of the 13F portfolio, value $44,785.
13F-HR 0001735057-26-000007 filed by Versant Capital Management, Inc
Accepted , ingested - period ended2026-06-3013F 958 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $27,303.
13F-HR 0001735057-26-000003 filed by Versant Capital Management, Inc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 958 sharesChange vs previous 13F +87 shares
<0.01% of the 13F portfolio, value $16,631.
13F-HR 0001735057-26-000002 filed by Versant Capital Management, Inc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 871 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $16,410.
13F-HR 0001735057-26-000001 filed by Versant Capital Management, Inc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 871 sharesChange vs previous 13F +776 shares
<0.01% of the 13F portfolio, value $12,664.
13F-HR 0001735057-25-000007 filed by Versant Capital Management, Inc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 95 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $1,856.
13F-HR 0001735057-25-000003 filed by Versant Capital Management, Inc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).